TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Research from Keio University, Medical Department in tuberculosis provides new insights
April 8th, 2008
"To examine the performance of an interferon-gamma (IFN-gamma) release assay (QuantiFERON-TB 2G assay [QFT-G]) to detect Mycobacterium tuberculosis infection in a Japanese general hospital, for the diagnosis of active pulmonary tuberculosis (PTB) and extra-pulmonary tuberculosis (EPTB). We prospectively examined the performance of QFT-G in 194 patients suspected of active TB," scientists in Tokyo, Japan report. "Diagnosis was confirmed by 1) positive M. tuberculosis cultures, or 2) clinical manifestations or laboratory or pathological findings consistent with active TB and response to specific therapy. Three patients with indeterminate QFT-G results were excluded. Among...
Source: TB & Outbreaks Week (2008-04-08)
|
